Dyslipidemia constitutes an essential risk factor for atherosclerotic disorders. From employing diverse types of blood lipid indicators as markers for risk prediction to subsequently applying low-density lipoprotein cholesterol as the primary lipid-lowering target in both primary and secondary prevention of cardiovascular diseases, relevant research and clinical practices indicate that the dyslipidemia management system grounded on hierarchical medical care is a significant measure for effective blood lipid control and efficient reduction of cardiovascular diseases. Continuously optimizing the prediction model for cardiovascular diseases, enhancing the construction of the medical consortium specializing in dyslipidemia disorders, and promoting the dyslipidemia management and control system based on hierarchical medical treatment will facilitate elevating the overall prevention and treatment level of dyslipidemia in China, and mitigate the health menace of cardiovascular diseases for Chinese residents.
